Tuberculosis (TB) is one of the leading infectious diseases in the world. Tuberculosis is caused by infection of the mycobacteria complex typically Mycobacterium tuberculosis (MTB). It is transmitted from person to person by respiratory droplets. The bacteria usually attack the lungs, but can infect any part of the body such as the kidney, intestine, pleura, spine, and brain.
Major factors driving growth of the global tuberculosis testing market is increasing global prevalence of tuberculosis infection. In addition, increased involvement of some of the world’s leading organizations such as WHO (World Health Organization) and FIND (Foundation for Innovative New Diagnostics), government grants towards research on tuberculosis and other government initiatives such as tax credit and fee waivers are fueling the growth of the market.
Request for the Sample Report Here: https://marketresearch.biz/report/tuberculosis-testing-market/request-sample/
The global tuberculosis testing market report has been segmented on the basis of test type, end-user and region.
On the basis of test type, the global tuberculosis testing market has been segmented into, nucleic acid testing (Nat), mantoux test (TST), smear microscopy, IGRA (interferon-gamma release assays), culture based tests, chest x-ray, xpert test, serological tests, others (including, drug susceptibility testing, adenosine deaminase (Ada) etc.). The culture based tests segment is projected to account for major share in terms of revenue in the global tuberculosis testing market during the forecast period mainly due to this test helps to diagnose and confirm active tuberculosis more accurately.
On the basis of end-user, the global tuberculosis testing market has been segmented into hospital laboratories, research laboratories, clinics laboratories, diagnostic center, others (including, home health agencies etc.). The hospital laboratories segment is estimated to account for significant share in the global tuberculosis testing market in terms of revenue.
On the basis of region, the global tuberculosis testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Market in Asia Pacific is estimated to account for major revenue share in the global tuberculosis testing market and is projected to register significant growth in terms of revenue in the next ten years, owing to increasing incidence of tuberculosis in countries such as India & China which in lead anticipated to propel growth of global tuberculosis testing market.
Key players operating in the global tuberculosis testing market include, LIONEX Diagnostics & Therapeutics GmbH, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Hain Life science GmbH, Creative Diagnostics, Abbott Laboratories, Becton, Dickinson and Company, Epistem Holdings Plc., Alere Inc., and Hologic Inc.